HomeSYNACT • STO
add
SynAct Pharma AB
Previous close
kr 22.90
Day range
kr 22.05 - kr 23.35
Year range
kr 7.24 - kr 25.30
Market cap
1.19B SEK
Avg Volume
183.62K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 35.38M | 45.53% |
Net income | -35.69M | -74.19% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.94M | 102.50% |
Total assets | 253.58M | 16.79% |
Total liabilities | 58.76M | 22.49% |
Total equity | 194.83M | — |
Shares outstanding | 52.90M | — |
Price to book | 6.22 | — |
Return on assets | -35.58% | — |
Return on capital | -44.87% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -35.69M | -74.19% |
Cash from operations | -25.75M | -6.96% |
Cash from investing | — | — |
Cash from financing | 34.93M | 28,272.58% |
Net change in cash | 9.05M | 137.22% |
Free cash flow | -13.24M | 27.89% |
About
Founded
Mar 14, 2012
Website
Employees
6
